The A to Z of pharmaceutical cocrystals: a decade of fast-moving new science and patents.

From aspirin to zoledronic acid, pharmaceutical cocrystals emerged in the past decade as a promising new weapon in the arsenal of drug development. Resurgence of interest in multicomponent crystal compositions has led to significant advances in the science of cocrystal design and discovery. These advances have built upon crystal engineering, which provides a deep understanding of supramolecular interactions between molecules that govern crystal packing and physicochemical properties of crystalline materials. Concomitantly, the patent landscape of pharmaceutical cocrystals developed rapidly in the last decade. This review presents a broad survey of patents issued in the area of pharmaceutical cocrystals. In addition, the review contains analyses of key patents in the area involving compositions and methodologies. Along the way, the main events of the past decade representing a renaissance of cocrystals of pharmaceutical materials are chronicled. Future directions in the area are discussed in light of key pending patent applications and recent publications of seminal interest.

[1]  F. Wöhler.  Untersuchungen über das Chinon , 1844 .

[2]  Jeanette T. Dunlap,et al.  Crystal engineering approach to forming cocrystals of amine hydrochlorides with organic acids. Molecular complexes of fluoxetine hydrochloride with benzoic, succinic, and fumaric acids. , 2004, Journal of the American Chemical Society.

[3]  Orn Almarsson,et al.  Crystal engineering of novel cocrystals of a triazole drug with 1,4-dicarboxylic acids. , 2003, Journal of the American Chemical Society.

[4]  J. McMahon,et al.  Crystal engineering of the composition of pharmaceutical phases. , 2003, Chemical communications.

[5]  William Jones,et al.  Solvent-drop grinding: green polymorph control of cocrystallisation. , 2004, Chemical communications.

[6]  J. Haleblian,et al.  Characterization of habits and crystalline modification of solids and their pharmaceutical applications. , 1975, Journal of pharmaceutical sciences.

[7]  E. Tiekink,et al.  What is a co-crystal? , 2008 .

[8]  M. Peterson,et al.  Hydrates and Solid-State Reactivity: A Survey of β-Lactam Antibiotics , 2007 .

[9]  Christer B. Aakeröy,et al.  Building co-crystals with molecular sense and supramolecular sensibility , 2005 .

[10]  Christopher T. Walsh,et al.  Drugs as materials: valuing physical form in drug discovery , 2004, Nature Reviews Drug Discovery.

[11]  Kenneth I. Hardcastle,et al.  Cocrystals of Piroxicam with Carboxylic Acids , 2007 .

[12]  Michael J. Zaworotko,et al.  Crystal engineering of the composition of pharmaceutical phases. Do pharmaceutical co-crystals represent a new path to improved medicines? , 2004 .

[13]  G. P. Stahly.  Diversity in Single- and Multiple-Component Crystals. The Search for and Prevalence of Polymorphs and Cocrystals , 2007 .

[14]  Gautam R. Desiraju,et al.  Supramolecular Synthons in Crystal Engineering ‐ A New Organic Synthesis , 1996 .

[15]  Margaret C. Etter,et al.  Hydrogen bonds as design elements in organic chemistry , 1991 .

[16]  A. M. Liquori,et al.  The crystal structure of 1:1 molecular complex between 1,3,7,9‐tetramethyluric acid and pyrene , 1965 .

[17]  M. Caira.  Molecular complexes of sulfonamides. 2.1:1 complexes between drug molecules: sulfadimidine-acetylsalicylic acid and sulfadimidine-4-aminosalicylic acid , 1992 .

[18]  D. D. Perrin,et al.  Purification of laboratory chemicals , 1966 .

[19]  M. Zaworotko,et al.  From molecules to crystal engineering: supramolecular isomerism and polymorphism in network solids. , 2001, Chemical reviews.

[20]  L. Leiserowitz,et al.  The molecular packing modes and the hydrogen-bonding properties of amide:dicarboxylic acid complexes , 1977 .

[21]  Gargi Mukherjee,et al.  Polymorphs, Salts, and Cocrystals: What’s in a Name? , 2012 .

[22]  T. Friščić,et al.  Supramolecular Control of Reactivity in the Solid State: From Templates to Ladderanes to Metal—Organic Frameworks , 2008 .

[23]  Michael J. Cima,et al.  Elucidation of crystal form diversity of the HIV protease inhibitor ritonavir by high-throughput crystallization , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[24]  Peddy Vishweshwar,et al.  Pharmaceutical co-crystals. , 2006, Journal of pharmaceutical sciences.

[25]  K. Nagapudi,et al.  Manufacture of pharmaceutical co-crystals using twin screw extrusion: a solvent-less and scalable process. , 2010, Journal of pharmaceutical sciences.

[26]  Sitaram P. Velaga,et al.  Formation of Cocrystals from Stoichiometric Solutions of Incongruently Saturating Systems by Spray Drying , 2010 .

[27]  J. Swarbrick.  Drugs and the pharmaceutical sciences , 1975 .

[28]  J. Niekerk,et al.  The crystal structure of the molecular complex of 4:4'‐dinitrodiphenyl with diphenyl , 1948 .

[29]  Michael J. Zaworotko,et al.  Crystal engineering : the design and application of functional solids , 1999 .

[30]  William Jones,et al.  Pharmaceutical Cocrystallization: Engineering a Remedy for Caffeine Hydration , 2005 .

[31]  Lena Ohannesian,et al.  Handbook of Pharmaceutical Analysis , 2001 .

[32]  Ashwini Nangia,et al.  Ternary and quaternary co-crystals of 1,3-cis,5-cis-cyclohexanetricarboxylic acid and 4,4′-bipyridines , 2008 .

[33]  J. H. T. Horst,et al.  Co-crystallization as a separation technology: controlling product concentrations by co-crystals , 2010 .

[34]  Ziyaur Rahman,et al.  Physicochemical and mechanical properties of carbamazepine cocrystals with saccharin , 2012, Pharmaceutical development and technology.

[35]  Sekhar Surapaneni,et al.  The co-crystal approach to improve the exposure of a water-insoluble compound: AMG 517 sorbic acid co-crystal characterization and pharmacokinetics. , 2008, Journal of pharmaceutical sciences.

[36]  Miranda L. Cheney,et al.  The Role of Cocrystals in Solid-State Synthesis: Cocrystal-Controlled Solid-State Synthesis of Imides , 2007 .

[37]  Gautam R. Desiraju,et al.  Crystal engineering : the design of organic solids , 1989 .

[38]  Changquan Calvin Sun,et al.  Understanding the relationship between crystal structure, plasticity and compaction behaviour of theophylline, methyl gallate, and their 1:1 co-crystal , 2010 .

[39]  William Jones,et al.  Pharmaceutical Cocrystals: An Emerging Approach to Physical Property Enhancement , 2006 .